ADTX ADITXT INC Company Mergers 8-K Filing 2024 - Merger Agreement Aditxt, Inc. entered into a merger agreement with Evofem Biosciences, Inc., with Evofem surviving as a wholly owned subsidiary of Aditxt. Evofem shareholders will receive $1.8 million in exchange for their common stock and their preferred stock will be converted into Aditxt preferred stock. The merger is subject to certain conditions and approvals.Get access to all SEC 8-K filings of the ADITXT INC